Member Info for StarKnight

Paraytec’s test is rapid, portable, reusable and does not require trained staff to operate it can be multiplexed which approx. 100 tests can be performed in a very short time. There are existing Worldwide patents in place and more applied for. The plan is for worldwide sales in every country. Think of all the lives that will be saved!
I know of two friends that died of Sepsis, one just after she gave birth. It is a horrible insidious disease.
Our device may possibly be an all test in one! I do not know how they plan on develop it and whether the software onboard the device will enable all tests. It may well be that the hardware of the device is the same as for a covid-19 test as per the same for a Sepsis test but with different software in which case you are able to double the number of units sold to the world-wide health centres. Then there is the Bladder Cancer test using the same device but adapted to test urine for cancer cells shredded by a tumour in the bladder.
This is being spun out in a new company called Sentinel in which we own 33% of the company so I can see a sale of our stake in Sentinel resulting in a very large SPECIAL DIVIDEND FOR ALL EXISTING SHARE HOLDERS IN BRAVEHEART! The future is very bright!

I would imagine there will be separate models for each clinical need.

Link to Antibiotic Research UK

https://www.antibioticresearch.org.uk/about-antibiotic-resistance/bacterial-infections/sepsis/?gclid=Cj0KCQjwvYSEBhDjARIsAJMn0ljeKyBGkpkgzMEyMq_mWpaqWmFOfnEDARJ4fNjyOM2Uxw88VF99urMaAhmcEALw_wcB

Braveheart’s 100% owned sub company Paraytec have identified an area of unmet medical need in the detection of Sepsis. Approx. 50 million people every year suffer from Sepsis and approx. 11 million people die from the it. Sepsis is a life-threatening organ disfunction which needs to receive anti-microbial therapy in the first hour for a good outcome, but for every hour that you go undiagnosed and not treated death is more likely. There are approx. 50 different micro-organisms such as bacteria and viruses that cause Sepsis. For treatment one needs to identify the bacteria or virus that is causing the Sepsis. Paraytec can test for all 50 micro-organisms in a matter of minutes which will save thousands if not millions of lives worldwide in early diagnosis of Sepsis but more importantly the actual one of FIFTY DIFFERENT BIOLOGICAL OR VIRUSES that are causing the Sepsis which then appropriate treatment can be administered.
See link below and at 12:58 minutes into the interview Professor Carl Smythe informs of our Rapid Sepsis Test which will be a modification to our rapid Covid-19 test I assume.

https://www.proactiveinvestors.co.uk/companies/news/943228/paraytec-lead-covid-19-professor-on-sensitivity-and-specificity-of-various-types-of-covid-19-tests-943228.html

Investing in Braveheart is AN ABSOLUTE MUST HAVE FOR YOUR PLAN TO MAKE MONEY ! IT IS A NO BRAINER !

IT IS AN ABSOLUTE BARGAIN ! AND WILL NEVER BE THIS LOW EVER AGAIN

Braveheart Investment Group (LON:BRH) share price surged 221.2% in 11 days to 128.50p (22/2/21) after issuing a stock market update on its work to develop Covid-19 tests.

Braveheart Investment Group is a diversified venture capital portfolio

Braveheart, though a financial services company, is a pure play on the technology sector. It is a venture capital-type of company, with a high-conviction strategy of investing in a small number of promising tech stocks offering the prospect of higher returns than would a properly diversified portfolio with more modest returns. Braveheart holds just five companies in its Strategic Investments portfolio, companies that it either controls or owns outright, and a portfolio of 12 other tech stocks.

The sudden surge in Braveheart Investment Group’s share price followed news that Paraytec, one of its key investments, is developing a Covid rapid testing kit that promises to deliver a result in five minutes. Its latest market update, issued this morning (1/3/21), confirms that the testing programme is on track, and ready to move on to the next trials stage.
The technology will also enable multiple simultaneous testing for public events, such as sports festivals and stadiums. As Braveheart CEO Trevor Brown said, “these latest laboratory results make clear that the Paraytec technology is capable of being market leading. Our attention will now turn towards quickly commencing the final clinical trial and commercialising our product either ourselves or with a partner.

Braveheart owns Paraytec outright, which means Paraytec’s company accounts – and its profits – are consolidated into Braveheart’s group accounts. Braveheart said it made a profit of £402,000 in the six months to end September 2020, against a loss of £122,000 in 2019, on revenues of £895,000 (2019: £250,000). The estimated value of the group’s strategic portfolio rose to £2.61m (2019: £1.1m) over the six months period. Group cash held for the period was up to £660,000, against liabilities of £281,000.

In November 2020, Braveheart sold its stake in Remote Monitored Systems for £17.4m, allocating much of the cash to increase its stake in one of its key investments, Phase Focus Ltd, which develops computational imaging techniques. The sale also allowed Braveheart to pay a special dividend of 42.75p per share, worth more than the share price at the time of 35.5p, worth £15.5m in total, as part of its policy of returning excess cash to investors ‘wherever practicable’.

Condensed article from The Arm Chair Trader link below

https://www.thearmchairtrader.com/braveheart-investment-group-share-price/

Managed to get in at 71.47 !

22-Apr-21 13:39:56 71.47 7,015 Buy* 70.00 72.00 £5,014 All fueled up and ready to rock !

Big money rolling in now ! Two £17.35K buys just gone through !

22-Apr-21 12:25:53 69.3895 25,000 Buy* 67.00 70.00 £17.35k
22-Apr-21 12:25:28 69.3895 25,000 Buy* 67.00 70.00 £17.35k

Hi ya busymum I hope you and family are well

I just tried to buy anothe £5K There is currently no online quote available. NT to buy !

@imac1

oops , no I do not love myself that much ha ha ha that was another post I think from L.as or Castlepaul that copied and pasted into my new post by mistake,I will remove it next time LOL

72 10,000 JBER 10:27
72 10,000 PEEL 09:39
72 7,500 SING 10:52
72 10,000 STFL 07:58

Our Paraytec device could potentially prevent your WIFE , HUSBAND , MOTHER , FATHER OR ANY OTHER FAMILY MEMBER OR FRIEND from dying and worse still not knowing who you are !!

Reposting for new investors

What treatment is available for Alzheimer’s or dementia?

THERE IS NO CURE FOR DEMENTIA! But people with Alzheimer’s might be prescribed a type of medication called cholinesterase inhibitors. There are three options: Donepezil, Rivastigmine or Galantamine. These medications work by preventing the breakdown of a chemical messenger (acetylcholine) which helps nerve cells in the brain communicate with each other.

Memantine can also be prescribed in the moderate to severe stage of Alzheimer’s disease alongside one of the above medications. This medication blocks the effects of excess glutamate in the brain and can help people with Alzheimer’s show some improvement with their memory, reasoning, language and attention.

If vascular dementia is caused by or related to heart disease, diabetes, or strokes, taking medication to control these conditions may prevent your dementia from getting worse.

Living healthily is the most important change you can make to help to reduce your risk of developing dementia or to slow down its progression, once diagnosed. There is evidence that what is good for the heart is also good for the brain. You can improve your brain function and overall health by eating a healthy balanced diet, giving up smoking, taking 150 minutes of moderate intensity activity per week e.g., brisk walking or cycling; and drinking alcohol in moderation. It is recommended that anyone over the age of 40 should attend an NHS Health Check every five years for early identification and treatment of physical health issues.

So once our WORLDS FIRST EVER FAST BLOOD TEST FOR ALZHEIMERS DISEASE is released millions of people will get an early diagnosis and lifesaving treatments before the onset of this mind destroying dreadful disease

GLOBAL SALES of a device the first in the world to test for Alzheimer’s disease from a quick blood test! Would you rather have that test with a POSITIVE / NEGATIVE DEFINATIVE ANSWER? or a test which is a questionnaire counting back from 100?

THIS IS GOING TO BE GLOBALLY EARTH SHATTERING!!

We are developing in collaboration the WORLD’S FIRST EVER FAST BLOOD TEST FOR ALZHEIMERS DISEASE THIS IS MONUMENTAL IN TERMS OF SAVING MILLION OF LIVES IN EARLY DIAGNOSIS PLUS HUGE REVENUES IN LICENCING AND ROYALTIES

This extract from Paraytec ( Braveheart ) website

Paraytec’s grant funded project (AD Scanner) to deploy its ActiPix™ technology in the field of Alzheimer’s disease (AD) diagnosis, working with a pan-European consortium of Karolinska Institute, Biomotif, Vrije University Medical Centre Amsterdam and MS Vision, is making good progress. The project is on target to complete in August 2021 and aims to produce and test the first instrument for the prognosis of Alzheimer’s Disease by fast and simple blood test. The automated AD Scanner prototype with fully tested software is now in use. The instrument uses capillary isoelectric focusing (cIEF), together with ActiPix™technology, to identify the level of protein biomarkers (abnormal proteoforms) in blood samples. If present, these abnormal proteoforms are indicative of the likely rate of mental decline for a given AD patient. This is important because such information could be used by clinicians in early diagnosis to differentiate AD patients from those with mild cognitive impairment, and also by researchers to help develop better drugs to counter this devastating disease. Research conducted by the Alzheimer’s Society shows that, in 2019, there were over 850,000 people with dementia in the UK. The Society considers that more than 520,000 people in the UK have dementia caused by Alzheimer’s disease and this figure is set to rise.

https://www.paraytec.com/research-projects-collaborations/

https://www.dementiauk.org/get-support/diagnosis-and-next-steps/getting-a-diagnosis-of-dementia/tests-for-dementia-and-alzheimers/?msclkid=241cf8dade021af68f66988e445aaf74&utm_source=bing&utm_medium=cpc&utm_campaign=Alzheimers%20Information%20%5BTier%203%5D&utm_term=tests%20for%20alzheimers&utm_content=Information%20-%20Tests%20For%20Alzheimer%27s

How does a GP test for dementia?

CURRENTLY THERE ARE NO PHYSICAL TESTS FOR DEMENTIA, SUCH AS A BLOOD TEST OR SCAN! There are, however, a range of tests that GPs will do, to rule out any other physical causes for the problems you are having. This might include blood tests to check for deficiencies or abnormalities. Other mental health conditions will also be ruled out such as depression, stress and anxiety. The test for depression a GP will give you is also a series of questions, about how you feel.

In addition, a GP might ask you a series of questions to establish if you are having problems with your concentration, memory, reasoning and spatial awareness. These might include asking what is the day, time or year; who the Prime Minister is; and asking you to perform a task, such as counting backwards from 100.

If you are taking a relative to the doctor about their memory, it is worth telling the GP any facts about your relative which might affect this test: for instance, someone who worked as an accountant or who has always been very good with numbers might continue to be good with numbers even with dementia. So, counting backwards from 100 might not be a good indication of cognitive impairment in that person.

If the GP does suspect that you or your relative might have some sort of cognitive impairment, they will probably refer you to a Memory Assessment Team/ Clinic or a dementia specialist.

Some symptoms of dementia can also look like depression, such as sleepiness or insomnia, and a lack of interest in things. Because of the similar symptoms, it is possible for people with dementia to be misdiagnosed with depression.

What tests for dementia will a Memory Assessment Clinic or specialist perform?
A member of the Memory Assessment Team will speak with you and your family member to find out more about the issues you are experiencing. They will want to know when the symptoms started, how this affects everyday living, and what you have been doing to try to manage this. They will also conduct a range of tests to examine your thinking and memory skills.

If you have suspected dementia, your Memory Clinic or specialist might perform a more detailed examination of your brain. This might be a CT (computed tomography) or MRI (magnetic resonance imaging) scan. This involves lying down in a large tube which either uses; magnets and radio waves (MRI scan) or X-rays (CT scan) to take very detailed pictures of the inside of your brain. These pictures can then be used to assess if there is damage to your brain, and in what part, which can allow the specialist to make a diagnosis of dementia and tell you what type of dementia you have. This information is important because the type of dementia you have affects the treatment that is available to you, as well as helping to explain what issues you might develop in the future.

The above is an extract from Dementia UK link to follow

Yes FIVE MAJOR PRODUCTS TO BE RELEASED and that is just from one of our sub companies Paraytec !

1. TWO MINUTE COVID-19 AND ALL VARIANTS RAPID SALIVA TEST

2. WORLD FIRST EVER RAPID BLOOD TEST FOR ALZHEIMERS DISEASE

3. NON-INVASIVE URINE TEST FOR BLADDER CANCER (BEING SPUN OUT IN A NEW SUB COMPANY CALLED SENTINEL)

4. EARLY DETECTION OF SEPSIS IN BLOOD

5. EARLY DETECTION OF CANCER

And then we have other companies too

https://braveheartgroup.co.uk/investments/

THIS IS GOING TO BE MASSIVE !!!

For new investors Paraytec is 100% owned by Braveheart Investment Group

Magnificent summary by StarKnight of 5 ground breaking, life changing, products. Thank you.

Regarding the new SARS-COV-2 Brittany variant that can only be detected deep in their lung tract or via a blood sample then our COVID-19 DIAGNOSTIC device can just be simply adapted to use a blood sample just like the adaptation of Paraytec device to detect cancer in urine or cancer in blood !

THIS MEANS OUR FIVE PRODUCTS WILL BE EVEN BETTER IMHO

Link to our sub 100 % owned company Paraytec in partnership with Sheffield University Professor Carl Smythe Genius !

https://www.paraytec.com/covid-19-test/

Reposting for new investors dyor gla

The development of our fast and sensitive COVID-19 test project uses a combination of existing intellectual property previously developed by Paraytec and also the creation of a wide range of new intellectual property within the fields of biochemistry, equipment hardware and software. Paraytec has employed specialist patent lawyers to assist with developing a pathway for the protection of the intellectual property and know how that has been developed during the creation of our COVID-19 test and to ensure that all novel intellectual property is protected by patents. Paraytec currently has a suite of five core patents granted and a further three patent applications submitted. Paraytec expects to be filing further additional patent applications over the first two quarters of 2021 as it develops the intellectual property around the COVID-19 test project.

So as our Paraytec device very closely conforms to the MHRA specifications I do not think it will be long before our device is brought to market (GLOBAL MARKET) with all required regulatory requirements!

Target Product Profile: Point of Care SARS-CoV-2 Detection Tests

PARAYTEC COVID-19 OPTICAL MEASUREMENT TEST

Here is the latest update 23rd March 2021 of the MHRA Target Product Profile (TPP) for a portable SARS-COV-2 Detection Test published by the UK Government MHRA Regulatory agency

This state the requirements of the MHRA to assist manufacturers to design and deliver tests that might be useful in support of the UK COIVD-19 testing strategy.

When compared with the brief description of our Paraytec Covid-19 Optical Test Device the specifications are very close and indeed the Paraytec specifications are more optimal in my opinion.

Link to MHRA Target Product Profile: Point of Care SARS-CoV-2 Detection Tests

https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/target-product-profile-point-of-care-sars-cov-2-detection-tests

PARAYTEC COVID-19 OPTICAL TEST
Designed to give a portable test, which can generate a result in a matter of 5 to 10 minutes (being revised) from a swab provided at the test location and which requires no specialist skills for its operation. It is anticipated that this product will be used in locations where the rapid screening of large numbers of people for presence of COVID-19, or any future emerging pandemic is required.
The key attributes for the testing device that we have determined are as follows:
• Simple swab or saliva sample – no clinical expertise needed
• No complex sample preparation – proprietary single-use cartridge containing analytes
• Simple portable reader – shoebox size
• No clinical training needed – automated test can be used in any location
• Rapid result – sample to result in 5 to 10 minutes, potential for further reduction
• yes/no result – option for quantification of viral load
• Platform technology – can potentially be used to detect multiple virus targets
Paraytec Scientific Concept
The test involves the deployment of a DNA aptamer – a short, single-stranded DNA molecule that adopts a shape that is complementary to that of the virus surface protein. By coating a test surface with millions of copies of the aptamer molecule, Paraytec’s CAPTURE module can trap Covid-19 virus particles from a swab sample, as they flow over the test surface. Trapped viruses are then instantaneously coated with the SIGNAL GENERATION module, a synthetic chimeric protein, that both recognises the viral surface as well as being highly fluorescent. The resultant fluorescent signal is measured by the novel DETECTION system developed using the company’s proprietary expertise in optics, electronics and software.

Continued

Reposting for new investors